Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes

Experimental and Molecular Medicine

Volumn 46, Issue 4, 2014, Pages

  Tsukamoto, Shokichi ^a,b   Takeuchi, Masahiro ^a,b   Kawaguchi, Takeharu ^a,b   Togasaki, Emi ^a,b   Yamazaki, Atsuko ^a,b   Sugita, Yasumasa ^a,b   Muto, Tomoya ^a,b   Sakai, Shio ^a,b   Takeda, Yusuke ^a,b   Ohwada, Chikako ^a,b   Sakaida, Emiko ^a,b   Shimizu, Naomi ^a,b   Nishii, Keigo ^b   Jiang, Meizi ^c   Yokote, Koutaro ^b   Bujo, Hideaki ^c   Nakaseko, Chiaki ^a,b  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

ADAM17; CD9; LR11; Tetraspanin; TNF converting enzyme

Indexed keywords

CD9 ANTIGEN; ILOMASTAT; INTERCELLULAR ADHESION MOLECULE 1; METALLOPROTEINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; TAMM HORSFALL GLYCOPROTEIN; TOLL LIKE RECEPTOR 11; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; CARRIER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SORL1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ARTICLE; CD9 GENE; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKOCYTE; LR11 GENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SHEDDING; GENETICS; MACROPHAGE; METABOLISM; TUMOR CELL LINE;

ADAM PROTEINS; ANTIGENS, CD9; CELL LINE, TUMOR; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LEUKOCYTES; MACROPHAGES; MEMBRANE TRANSPORT PROTEINS; PROTEOLYSIS;

EID: 84902196714     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2013.161     Document Type: Article

References (28)

1. Yamazaki H, Bujo H, Kusunoki J, Seimiya K, Kanaki T, Morisaki N et al. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem 1996;271:24761-24768.
2. Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K et al. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol 2001;21:1501-1506.
3. Zhu Y, Bujo H, Yamazaki H, Ohwaki K, Jiang M, Hirayama S et al. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration. Circ Res 2004;94:752-758.
4. Jiang M, Bujo H, Ohwaki K, Unoki H, Yamazaki H, Kanaki T et al. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest 2008;118:2733-2746.
5. Takahashi M, Bujo H, Shiba T, Jiang M, Maeno T, Shirai K. Enhanced circulating soluble LR11 in patients with diabetic retinopathy. Am J Ophthalmol 2012;154:187-192.
6. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007;39:168-177.
7. Ikeuchi T, Hirayama S, Miida T, Fukamachi I, Tokutake T, Ebinuma H et al. Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease. Dement Geriatr Cogn Disord 2010;30:28-32.
8. Guo LH, Westerteicher C, Wang XH, Kratzer M, Tsolakidou A, Jiang M et al. SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2012;262:529-534.
9. Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S et al. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clin Chim Acta 2012;413:1542-1548.
10. Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y et al. LR11: a novel biomarker identified in follicular lymphoma. Br J Haematol 2013;163:277-280.
11. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-289.
12. Mezyk R, Bzowska M, Bereta J. Structure and functions of tumor necrosis factor-alpha converting enzyme. Acta Biochim Pol 2003;50:625-645.
13. Scheller J, Chalaris A, Garbers C, Rose-John S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 2011;32:380-387.
14. Guo L, Eisenman JR, Mahimkar RM, Peschon JJ, Paxton RJ, Black RA et al. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol Cell Proteomics 2002;1:30-36.
15. Hampe W, Riedel IB, Lintzel J, Bader CO, Franke I, Schaller HC. Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. J Cell Sci 2000;113:4475-4485.
16. Gutierrez-Lopez MD, Gilsanz A, Yanez-Mo M, Ovalle S, Lafuente EM, Dominguez C et al. The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell Mol Life Sci 2011;68:3275-3292.
17. Matsuo M, Ebinuma H, Fukamachi I, Jiang M, Bujo H, Saito Y. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis. Clin Chem 2009;55:1801-1808.
18. Ohwaki K, Bujo H, Jiang M, Yamazaki H, Schneider WJ, Saito Y. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler Thromb Vasc Biol 2007;27:1050-1056.
19. Leung KT, Chan KY, Ng PC, Lau TK, Chiu WM, Tsang KS et al. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34 + hematopoietic stem and progenitor cells. Blood 2011;117:1840-1850.
20. Huang CL, Liu D, Masuya D, Kameyama K, Nakashima T, Yokomise H et al. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 2004;23:7475-7483.
21. Gliemann J, Hermey G, Nykjaer A, Petersen CM, Jacobsen C, Andreasen PA. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand. Biochem J 2004;381:203-212.
22. Hermey G, Sjogaard SS, Petersen CM, Nykjaer A, Gliemann J. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem J 2006;395:285-293.
23. Yanez-Mo M, Gutierrez-Lopez MD, Cabanas C. Functional interplay between tetraspanins and proteases. Cell Mol Life Sci 2011;68:3323-3335.
24. Mazurov D, Barbashova L, Filatov A. Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes. FEBS J 2013;280:1200-1213.
25. Arduise C, Abache T, Li L, Billard M, Chabanon A, Ludwig A et al. Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor. J Immunol 2008;181:7002-7013.
26. Nishii K, Nakaseko C, Jiang M, Shimizu N, Takeuchi M, Schneider WJ et al. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells. J Biol Chem 2013;288:11877-11886.
27. Charbonneau M, Harper K, Grondin F, Pelmus M, McDonald PP, Dubois CM. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. J Biol Chem 2007;282:33714-33724.
28. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 2010;9:1085-1099.